Manage subscriptions

You can follow the discussion on Mobius Therapeutics, LLC Issues a Voluntary Recall of Mitosol® (mitomycin forsolution), 0.2 mg/vial, Kit for Ophthalmic Use without having to leave a comment. Cool, huh? Just enter your email address in the form here below and you’re all set.